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Given that many brain disorders are characterized by mitochondrial dysfunction, there is a growing 23 interest in investigating genetic and epigenetic variation in mitochondrial DNA (mtDNA). One major 24 caveat for such studies is the presence of nuclear-mitochondrial pseudogenes (NUMTs), which are 25 regions of the mitochondrial genome that have been inserted into the nuclear genome over evolution 26 and, if not accounted for, can confound genetic studies of mtDNA. Here we show the first systematic 27 study to compare methods for isolating mtDNA from frozen post-mortem human brain tissue, and 28
show that a commercial method from Miltenyi Biotech, which magnetically isolates mitochondria 29 using antibodies raised against TOM22, gives a significant enrichment of mtDNA, and should be 30 
Method Summary 37
Here we compare five methods of isolating mitochondrial DNA (mtDNA) to standard phenol-38 chloroform DNA extraction (that isolates nuclear DNA (ncDNA) and mtDNA) to determine the 39 optimal method for enriching mtDNA from frozen post-mortem human brain tissue. Mitochondria are unique mammalian organelles in that they contain their own genome; the 49 mitochondrial genome is ~16.6kb of circular DNA (mtDNA) [7] , separate to the nuclear genome 50 (ncDNA) and inherited in a maternal, non-Mendelian fashion. The mitochondrial genome comprises 51 37 genes; 13 encode for electron transport chain polypeptides, two for rRNAs and 22 for tRNAs. 52
Because of its role in ROS production, mtDNA has a higher mutation rate (10-17 fold) than ncDNA 53
[8]. Mutations in mtDNA are relatively common, with at least one in 200 healthy humans harboring a 54 potentially pathogenic mtDNA mutation [9] . Indeed more than 300 point mutations in mtDNA are 55 associated with disease risk and pathology in MitoMAP [10] . Interestingly, as each mitochondrion 56 contains 2-10 copies of mtDNA and there are multiple mitochondria in any given cell, somatic 57 mutations result in a mosaic of different mtDNA sequences within a given tissue. This phenomenon is 58 known as mitochondrial heteroplasmy and is linked to various mitochondrial diseases [11] . Such 59 heterogeneity is a potential confounder in studies of mitochondrial diseases, because inter-and intra-60 individual heteroplasmic variation can confuse the association between a haplogroup and its 61 corresponding phenotype. Therefore, unlike studies of ncDNA variation, it is important to use the 62 specific tissue of interest for etiological research. Another interesting feature of the mitochondria is 63 that over evolution sequences of mtDNA have translocated to the nuclear genome. Traditional 64 mitochondrial genetic research, and more recently studies of mitochondrial epigenetics, can be 65 hampered by the presence of these nuclear-mitochondrial pseudogenes (NUMTs) as they share a high 66 homology with their mitochondrial paralogs [12, 13] . Given the interest in studying mtDNA genetic 67 and epigenetic changes in the pathology of brain diseases characterized by mitochondrial dysfunction, 68 it is imperative that NUMTs are correctly accounted for [14] . 69
The specific isolation of mitochondria prior to downstream processing is vital to fully exclude issues 70 relating to NUMT contamination. For this purpose, a number of methods have been developed to 71 specifically isolate mtDNA, although few of these approaches have been specifically optimized for 72 use on post-mortem tissue, a major resource in many epidemiological studies. In fact most studies 73 investigating mtDNA use fresh animal tissue or cell lines. The insult of freezing tissue prior to 74 isolation will potentially alter the effectiveness of these techniques and increase the risk of NUMT 75 inclusion in downstream analysis. In this study we compared the effectiveness of five different 76 mitochondrial isolation methods on post-mortem brain tissue using quantitative real-time PCR (qRT-77 PCR), to determine the optimal method for the specific enrichment of mtDNA, which was 78 subsequently validated by next generation sequencing (NGS). We tested protocols based on A) 79
Percoll gradients, B) linear DNA digestion, C) differential centrifugation, D) rapid differential 80 centrifugation using a commercial kit and E) magnetic isolation of mitochondria using anti-TOM22 81
antibodies. Storage Buffer and centrifuged at 13,000xg for 2 minutes at 4°C. The supernatant was discarded and 117 mtDNA extracted using a DNA Mini Kit (Qiagen:51304). We compared these approaches to DNA we 118 had previously isolated [17] using a phenol-chloroform protocol, which isolates both ncDNA and 119 mtDNA We assessed the purity of each method using qRT-PCR as previously described (6). Briefly, 120 the number of copies of mtDNA relative to ncDNA was determined by dividing the calculated 121 number of copies of mtDNA (MT-CYB assay) by the calculated number of copies of ncDNA (B2M 122 assay). 123
Our data showed that Method B (linear DNA digestion) gave the lowest purity (1,242 mtDNA 124 copies/ncDNA copy), and Method E (magnetic-microbeads) the highest purity (14,654 mtDNA6 copies/ncDNA copy) ( Figure 1A ; Table 1 ). Of particular interest to the study was the relative 126 enrichment compared to a standard phenol-chloroform extraction ( Figure 1B) . The only method to 127
show no enrichment was Method B (linear DNA digestion). All other techniques showed a positive 128 enrichment of mtDNA compared to phenol-chloroform. Methods A (Percoll), C (differential 129 centrifugation) and D (rapid differential centrifugation) all gave modest positive enrichments of 2.4-, 130
1.7-and 2.9-fold respectively. Although giving one of the lowest yields (3.2µg), the optimal method 131 for enrichment relative to ncDNA was Method E (magnetic-microbeads), which gave a 10.7-fold 132 enrichment, and was the only method to show significantly more copies of mtDNA/ncDNA copy 133 compared to phenol-chloroform extraction (P=1.88x10 -3 ). Using this method we saw a significant 134 enrichment of mtDNA/ncDNA compared to Methods A (P=0.019), B (P=6.97x10 -4 ) and C 135 (P=8.48x10 -3 ). To validate our enrichment, two of the biological replicates from Method E were 136 compared to a non-enriched standard from phenol-chloroform extraction using NGS. DNA samples 137 were fragmented by sonication using a Bioruptor (Diagenode:UCD-200) to an average size of 138 ~240bp. Sequencing libraries were prepared using the NEXTflex Rapid DNA-Seq kit (Bioo 139 Scientific) and ligated to pre-indexed adapters (NEXTflex-96 DNA Barcodes; Bioo Scientific). 140
Adapter-ligated DNA was amplified for 10 cycles using Herculase II Fusion DNA Polymerase 141 (Agilent Technologies) and NEXTflex PCR primer mix, then pooled for sequencing on an Illumina 142 HiSeq2500 (100bp paired-end, rapid run mode). Raw reads were quality and adaptor trimmed using 143 TrimGalore! (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) before being aligned 144 to GRCH37. Only high quality (Phred <20) reads, uniquely mapping to the genome were considered 145 and total read counts were taken. For the non-enriched standard 1.1% of reads mapped to the 146 mitochondrial genome, compared to an average of 18.7% (16.2% and 21.2% respectively) of reads 147
with Method E, demonstrating an average 16.8 fold enrichment. cell lines and blood, may be more degraded in frozen, archived brain. In the context of genomic 154 studies of mtDNA, where the exclusion of NUMTs is imperative, the relative enrichment of mtDNA is 155 of far greater importance than the yield. Thus, although we saw a lower yield with magnetic-156 microbeads (Method E) compared to the majority of methods tested, we observed the greatest purity 157 with this method. The reasons for the observed greater enrichment of mtDNA/ncDNA relative to 158
Percoll (Method A) in our study compared to the analysis by Hornig-Do and colleagues potentially 159 may include i) our use of qRT-PCR, which is more sensitive than western blot, ii) our use of frozen 160 samples, rather than fresh samples and iii) the use of brain, rather than a cell line, as brain has high 161 levels of mitochondria. To our knowledge our study represents the first to systematically compare and 162 contrast methods for isolating mtDNA from small quantities of frozen, post-mortem human brain. Our 163 findings suggest that magnetic-microbeads provide a significant enrichment of mtDNA compared to 164 any other method tested. This may be due to a number of reasons, for example the automated 165 homogenization of tissue in this protocol could provide a more consistent and gentle approach than 166 other techniques and the use of magnetically labelled antibodies provides a specific capture of intact 167 mitochondria, which may also contain less degraded mtDNA. We recommend that given the current 168 to a non-enriched standard (phenol-chloroform (F)). Shown is the ratio of mtDNA/ncDNA (±SEM) (Fig 1A) and the relative enrichment compared to phenol-chloroform (Fig 1B) . *** = P<0.005
